Anna Plym

Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer.

Ma C, Ericsson C, Carlsson SV, Lilja H, Kibel A, Graff RE, Plym A, Giovannucci E, Mucci LA, Preston MA, Penney KL.

Eur Urol Open Sci. 2023 Apr. 50:27-30. PMID: 36861107

Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention.

Seibert TM, Garraway IP, Plym A, Mahal BA, Giri V, Jacobs MF, Cheng HH, Loeb S, Helfand BT, Eeles RA, Morgan TM.

Eur Urol. 2023 Mar. 83(3):241-248. PMID: 36609003

Differences in Prostate Cancer Transcriptomes by Age at Diagnosis: Are Primary Tumors from Older Men Inherently Different?

Zhou CD, Pettersson A, Plym A, Tyekucheva S, Penney KL, Sesso HD, Kantoff PW, Mucci LA, Stopsack KH.

Cancer Prev Res (Phila). 2022 12 01. 15(12):815-825. PMID: 36125434

Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years.

Plym A, Zhang Y, Stopsack KH, Jee YH, Wiklund F, Kibel AS, Kraft P, Giovannucci E, Penney KL, Mucci LA.

Clin Cancer Res. 2022 11 14. 28(22):4926-4933. PMID: 36103261

Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.

Chen F, Darst BF, Madduri RK, Rodriguez AA, Sheng X, Rentsch CT, Andrews C, Tang W, Kibel AS, Plym A, Cho K, Jalloh M, Gueye SM, Niang L, Ogunbiyi OJ, Popoola O, Adebiyi AO, Aisuodionoe-Shadrach OI, Ajibola HO, Jamda MA, Oluwole OP, Nwegbu M, Adusei B, Mante S, Darkwa-Abrahams A, Mensah JE, Adjei AA, Diop H, Lachance J, Rebbeck TR, Ambs S, Gaziano JM, Justice AC, Conti DV, Haiman CA.

Elife. 2022 07 08. 11. PMID: 35801699

5-Alpha Reductase Inhibitors and Prostate Cancer Mortality among Men with Regular Access to Screening and Health Care.

Vaselkiv JB, Ceraolo C, Wilson KM, Pernar CH, Rencsok EM, Stopsack KH, Grob ST, Plym A, Giovannucci EL, Olumi AF, Kibel AS, Preston MA, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2022 07 01. 31(7):1460-1465. PMID: 35255119

A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer.

Plym A, Zhang Y, Stopsack KH, Delcoigne B, Wiklund F, Haiman C, Kenfield SA, Kibel AS, Giovannucci E, Penney KL, Mucci LA.

Eur Urol. 2022 May 27. PMID: 35637041

Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer.

Plym A, Penney KL, Kalia S, Kraft P, Conti DV, Haiman C, Mucci LA, Kibel AS.

J Natl Cancer Inst. 2022 05 09. 114(5):771-774. PMID: 33792693

Metabolic syndrome and its pharmacologic treatment are associated with the time to castration-resistant prostate cancer.

Geng JH, Plym A, Penney KL, Pomerantz M, Mucci LA, Kibel AS.

Prostate Cancer Prostatic Dis. 2022 02. 25(2):320-326. PMID: 35075214

DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American Men.

Plym A, Dióssy M, Szallasi Z, Sartor O, Silberstein J, Powell IJ, Rebbeck TR, Penney KL, Mucci LA, Pomerantz MM, Kibel AS.

JNCI Cancer Spectr. 2022 02. 6(1). PMID: 35079693